Gaize

Real-Time Drug Impairment Detection

Contact for Pricing

Description

Gaize provides advanced impairment detection technology designed for workplace safety. It utilizes automated eye tests, based on the well-established Drug Recognition Expert (DRE) ocular assessments used by law enforcement for over 45 years, to identify signs of current impairment from a broad spectrum of substances, including marijuana, alcohol, opioids, and stimulants. The system performs these tests in just six minutes, delivering objective, real-time results without the need for bodily fluids.

This technology offers businesses a reliable and legally defensible method to enhance safety protocols, especially concerning reasonable suspicion scenarios. By focusing on current impairment rather than past substance use, Gaize helps companies maintain safety standards while potentially retaining valuable employees who use substances like cannabis responsibly on their own time. The platform provides clear, downloadable reports and video evidence for each test, integrating seamlessly into existing safety programs and offering significant cost and time savings compared to traditional lab-based testing.

Key Features

Broad Spectrum Drug Impairment Detection: Identifies impairment from marijuana, alcohol, opioids, stimulants, dissociatives, and some psychedelics.
Rapid Testing: Delivers results in just 6 minutes.
High Accuracy: Over 98% accurate at detecting known indicators of impairment.
Objective Evidence: Provides automated testing results backed by human-interpretable video.
DRE-Based Automated Ocular Tests: Uses automated versions of proven law enforcement eye tests.
Non-Invasive: Requires no bodily fluids or biometric information.
Real-Time Reporting: Instantly stores and reports results, accessible from anywhere.
Legally Defensible: Based on established DRE standards and is 50-state legal in the US.
Cost-Effective: Significantly cheaper and faster than traditional lab-based chemical testing.

Use Cases

Enhancing workplace safety programs in safety-sensitive industries.
Supporting reasonable suspicion drug testing protocols.
Deterring drug and alcohol impairment on the job.
Reducing costs associated with traditional chemical drug testing.
Improving employee retention by differentiating current impairment from past THC use.
Providing objective evidence for HR and safety decisions.